Correlation Between Navidea Biopharmaceutica and Xilio Development

Can any of the company-specific risk be diversified away by investing in both Navidea Biopharmaceutica and Xilio Development at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Navidea Biopharmaceutica and Xilio Development into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Navidea Biopharmaceuticals and Xilio Development, you can compare the effects of market volatilities on Navidea Biopharmaceutica and Xilio Development and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Navidea Biopharmaceutica with a short position of Xilio Development. Check out your portfolio center. Please also check ongoing floating volatility patterns of Navidea Biopharmaceutica and Xilio Development.

Diversification Opportunities for Navidea Biopharmaceutica and Xilio Development

-0.29

Correlation Coefficient

Navidea Biopharmaceutica  Xilio Development

Very good diversification

The 3 months correlation between Navidea and Xilio is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Navidea Biopharmaceuticals and Xilio Development in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xilio Development and Navidea Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Navidea Biopharmaceuticals are associated (or correlated) with Xilio Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xilio Development has no effect on the direction of Navidea Biopharmaceutica i.e., Navidea Biopharmaceutica and Xilio Development go up and down completely randomly.

Pair Corralation between Navidea Biopharmaceutica and Xilio Development

If you would invest  105.00  in Xilio Development on August 31, 2024 and sell it today you would earn a total of  4.00  from holding Xilio Development or generate 3.81% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	0.79%
Values	Daily Returns

Navidea Biopharmaceuticals  vs.  Xilio Development

Navidea Biopharmaceutica

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Navidea Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Navidea Biopharmaceutica is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Xilio Development

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Xilio Development are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very weak essential indicators, Xilio Development displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Navidea Biopharmaceutica and Xilio Development

The main advantage of trading using opposite Navidea Biopharmaceutica and Xilio Development positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Navidea Biopharmaceutica position performs unexpectedly, Xilio Development can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xilio Development will offset losses from the drop in Xilio Development's long position.

The idea behind Navidea Biopharmaceuticals and Xilio Development pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.